(Q37945097)

25 August 2017

title

LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications (English)

1 reference

25 August 2017

0 references

1 reference

Meiling Yan

1

1 reference

25 August 2017

Jawahar L Mehta

series ordinal

2

1 reference

25 August 2017

Weifang Zhang

series ordinal

3

1 reference

25 August 2017

Changping Hu

series ordinal

4

1 reference

25 August 2017

publication date

1 October 2011

1 reference

Cardiovascular Drugs and Therapy

25 August 2017

published in

1 reference

25 August 2017

volume

25

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

451-459

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Diabetic complications and dysregulated innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Future strategies to prevent renal microvascular disease complications in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

An endothelial receptor for oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Susceptibility of low-density lipoprotein to oxidation and circulating cell adhesion molecules in young healthy adult offspring of parents with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Mechanisms for oxidative stress in diabetic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

High glucose induces IL-1beta expression in human monocytes: mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Activation of peripheral blood CD14+ monocytes occurs in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Pathogenetic mechanisms of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

How does angiotensin II cause renal injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Diabetic nephropathy: where hemodynamics meets metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Redox-sensitive regulation of lox-1 gene expression in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Downregulation of lectin-like oxidized low-density lipoprotein receptor-1 after ischemic preconditioning in ischemia-reperfused rat kidneys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Deletion of LOX-1 attenuates renal injury following angiotensin II infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Linoleic acid increases lectin-like oxidized LDL receptor-1 (LOX-1) expression in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the tubulointerstitial area likely plays an important role in human diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Oxidized high-density lipoprotein enhances inflammatory activity in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Statins and angiogenesis: is it about connections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

Antiangiogenic and antimitotic effects of aspirin in hypoxia–reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6342-4

10.1007/S10557-011-6342-4

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference